Study of Individuals Affected With Hypoplasminogenemia
Public ClinicalTrials.gov record NCT03797495. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Hypoplasminogenemia: An International RetroSpecTive and PrOspective CohoRt StudY (HISTORY)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is an Investigator initiated retrospective and prospective single cohort study. The study will utilize an international registry and develop a specimen biobank to provide an improved understanding of the natural history of hyposplasminogenemia, to elucidate the heterogeneity of phenotypic expression, identify markers to predict disease course, and inform improved therapeutic modalities
Study identification
- NCT ID
- NCT03797495
- Recruitment status
- Recruiting
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 100 participants
Conditions and interventions
Conditions
Interventions
Not listed
Eligibility (public fields only)
- Age range
- Not listed
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 17, 2018
- Primary completion
- Jun 28, 2029
- Completion
- Nov 25, 2029
- Last update posted
- Jun 3, 2026
2018 – 2029
United States locations
- U.S. sites
- 13
- U.S. states
- 10
- U.S. cities
- 13
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| The University of Alabama (UAB) | Birmingham | Alabama | 35233 | Recruiting |
| Rush University Medical Center | Chicago | Illinois | 60612 | Recruiting |
| Indiana Hemophila @Thrombosis Center | Indianapolis | Indiana | 46260 | Recruiting |
| University of Minnesota, Pediatric Hem/Onc & Cancer Survivorship Program | Minneapolis | Minnesota | 55455 | Recruiting |
| Stony Brook University | Stony Brook Medicine | East Setauket | New York | 11733 | Recruiting |
| SUNY Upstate Medical University, Pediatric Hematology/Oncology | Syracuse | New York | 13210 | Recruiting |
| University of North Carolina at Chapel Hill | Raleigh | North Carolina | 27599 | Recruiting |
| Wake Forest University | Winston-Salem | North Carolina | 27157 | Recruiting |
| Hemophilia Center of Western Pennsylvania | Pittsburgh | Pennsylvania | 15213 | Recruiting |
| Vanderbilt Children's Hematology-Oncology | Nashville | Tennessee | 37232 | Completed |
| Cook Children's Medical Center | Forth Worth | Texas | 76104 | Recruiting |
| The University of Texas Health Science Center at Houston | Houston | Texas | 77030 | Completed |
| Seattle Children's Hospital | Seattle | Washington | 98105-3901 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 22 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03797495, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 3, 2026 · Synced Sep 10, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03797495 live on ClinicalTrials.gov.